Discover 1,655 paid clinical trials in Raleigh, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,655
Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial)
for
Core Binding Factor Acute Myeloid Leukemia
Location: Durham NC, Richmond VA, Boiling Springs SC, Greer SC,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 59
Code: NCT06917911
Phase 2, Recruiting
GORE® TAG® Thoracic Branch Endoprosthesis Zone 0/1 Post-Approval Study
for
Aortic Arch Dissection, Aortic Arch Aneurysm
Location: Durham NC, Chapel Hill NC, Washington D.C. DC,
Sponsor: W.L.Gore & Associates
Sex: All
Age: 18+
Code: NCT07166133
Recruiting
Characterizing the Microvascular Environment of Bladder Cancer With Super-Resolution Ultrasound Localization Microscopy
for
Bladder Cancer
Location: Durham NC
Sponsor: Duke University
Sex: All
Age: 18+
Code: NCT06986304
Recruiting
A Study of PHN-012 in Patients With Advanced Solid Tumors
for
Colon Cancer, Pancreatic Cancer, Lung Cancer (NSCLC),
Location: Durham NC, Fairfax VA, Washington D.C. DC, Nashville TN,
Sponsor: Pheon Therapeutics
Sex: All
Age: 18+
Code: NCT07127874
Phase 1, Recruiting
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
Location: Durham NC, Chapel Hill NC, Norfolk VA, Augusta GA,
Sponsor: W.L.Gore & Associates
Sex: All
Age: 18+
Code: NCT06658730
Recruiting
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
for
Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia
Location: Durham NC, Chapel Hill NC, Greenville NC,